Home LiteratureArticle Details
PMID: 15790362 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

The stages of type 1A diabetes: 2005.

Immunological reviews ·Vol. 204 ·2005-04-00 ·Pages 232-49

Gianani R, Eisenbarth GS

Abstract

Type 1A diabetes is a chronic autoimmune disease usually preceded by a long prodrome during which autoantibodies to islet autoantigens are present. These antibodies are directed to a variety of antigens, but the best characterized are glutamic acid decarboxylase-65, insulinoma-associated antigen-2, and insulin. We hypothesize that the natural history of type 1A diabetes can be represented by several stages, starting from genetic susceptibility and ending in complete beta-cell destruction and overt diabetes. Type 1A diabetes probably results from a balance between genetic susceptibility and environmental influences. In both humans and animal models, the major determinants of the disease are genes within the major histocompatibility complex. The next best-characterized susceptibility locus is the insulin gene, the variable nucleotide tandem repeat locus. This gene affects the expression of insulin in the thymus and thus may play a role in the modulation of tolerance to this molecule. In a subset of genetically susceptible individuals, the activation of autoimmunity may be triggered by environmental factors such as viruses and/or diet. However, no conclusive association has been established between type 1A diabetes and specific environmental triggers. In this review, we provide evidence that insulin has a fundamental role in anti-islet autoimmunity.

MeSH Terms
Animals Autoantibodies/immunology Autoantigens/immunology Diabetes Mellitus, Type 1/genetics,immunology,physiopathology,therapy Humans Insulin/metabolism Insulin Secretion Islets of Langerhans/immunology,metabolism,pathology
Chemicals
Autoantibodies Autoantigens Insulin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Gianani Roberto
The Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO, USA. roberto.gianani@uchsc.edu
Eisenbarth George S
Article Info
Journal
Immunological reviews
Abbr.
Immunol Rev
ISSN
0105-2896
Published
2005-04-00
Pages
232-49
Language
English
Region
England
NLM ID
7702118
Subset
IM
Grants
NIAID NIH HHS · AI15416 · United States
NIAID NIH HHS · AI39213 · United States
NIAID NIH HHS · AI50864 · United States
NIDDK NIH HHS · DK32083 · United States
NIDDK NIH HHS · DK32493 · United States
NIDDK NIH HHS · DK55969 · United States
NIDDK NIH HHS · DK62718 · United States
NCRR NIH HHS · M01 RR00051 · United States
NCRR NIH HHS · M01 RR00069 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com